Industry Research Reports

Home > Reports > Chemical & Material > Global Hirudin Market Research Report 2025

Global Hirudin Market Research Report 2025

Industry: Chemical & Material

Published Date: 2025-06-11

Pages: 114 Pages

Report ld: 3468238

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Hirudin Market Size(US$)

CAGR 2025-2031

3.1%

Market Size,2031

USD 5,214

Million

Market Snapshot

Market Size in 2025 (Value)

US$ 4,341 million

Market Forecast in 2031(Value)

US$ 5,214 million

CAGR

3.1%

Years Considered

2020-2031

Base Year

2025

Forecast Period

2025-2031

Source: Secondary research, interviews with experts, and QYResearch analysis

The global market for Hirudin was valued at US$ 4223 million in the year 2024 and is projected to reach a revised size of US$ 5214 million by 2031, growing at a CAGR of 3.1% during the forecast period.

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Hirudin competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.

Hirudin is a potent anticoagulant protein originally derived from the salivary glands of the medicinal leech (Hirudo medicinalis). Its mechanism of action involves directly binding to thrombin, the enzyme responsible for converting fibrinogen into fibrin during the clotting process, thus preventing blood coagulation. This unique property makes hirudin a highly effective anticoagulant, especially in patients at risk of thrombus formation. With the advancement of biotechnology, the production of hirudin has shifted from being sourced directly from leeches to large-scale synthesis through recombinant DNA technology in laboratories. Currently, hirudin is primarily used in the treatment of thrombotic conditions such as deep vein thrombosis (DVT), pulmonary embolism, and certain types of strokes. It is considered an effective alternative for patients who are allergic or intolerant to traditional anticoagulants like heparin. Over the years, with increasing research into hirudin’s applications, various derivatives and related drugs, such as lepirudin and desirudin, have been developed, broadening its clinical use.

The market development of hirudin is driven by several factors. Firstly, the growing global demand for the treatment of thrombotic diseases, particularly among cardiovascular patients and post-surgical individuals, presents significant opportunities for hirudin and its derivatives. With the aging population and the increasing prevalence of thrombotic and vascular diseases, there is a rising demand for effective anticoagulants. Secondly, hirudin's unique mechanism of action offers advantages in treating certain conditions, particularly for patients who are allergic to traditional anticoagulants like heparin, further driving the market for hirudin products.

However, the hirudin market faces challenges and risks. The production cost remains high, particularly in the early stages when biotechnology was not fully developed, limiting its widespread use. Additionally, although hirudin has strong anticoagulant effects, its use requires careful monitoring of the patient's coagulation function to prevent the risk of bleeding.

In terms of market concentration, as production technologies for hirudin mature, the market has become more concentrated in the hands of a few large pharmaceutical companies that maintain their market share through acquisitions, research and development, and patented technologies. The downstream demand trend is diversifying, with hirudin finding applications not only in traditional thrombotic disease treatment but also in other coagulation disorders and post-surgical care. Recent technological advances include the recombinant production of hirudin using genetic engineering, which has significantly improved production efficiency and lowered costs, potentially expanding the use of hirudin in the future.

biaoTi REPORT SCOPE

This report aims to provide a comprehensive presentation of the global market for Hirudin, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hirudin.

The Hirudin market size, estimations, and forecasts are provided in terms of output/shipments (Tons) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Hirudin market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Hirudin manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

By Company

Novartis

Teva Pharmaceuticals

Pfizer, Inc

Pentapharm

DUOPUTAI

Abbott

Keyken

Minapharm

Salubris Bio

Hoechst AG

Ciba-Geigy

Boehringer Ingelheim

Sanofi

Xellia Pharmaceuticals

Haplogen Pharmaceuticals

Shenzhen Kangtai Biological

Dong-A ST

Segment by Type

Natural Hirudin

Recombinant Hirudin

Segment by Application

Thrombosis Disease

Tumor Disease

Others

Production by Region

North America

Europe

China

Japan

Consumption by Region

North America

U.S.

Canada

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Indonesia

Thailand

Malaysia

Europe

Germany

France

U.K.

Italy

Russia

Latin America

Mexico

Brazil

Argentina

Middle East and Africa

Turkey

Saudi Arabia

UAE

biaoTi CHAPTER OUTLINE

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Detailed analysis of Hirudin manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Production/output, value of Hirudin by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 4: Consumption of Hirudin in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 10: The main points and conclusions of the report.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Hirudin Market Overview

1.1 Product Definition

1.2 Hirudin by Type

1.2.1 Global Hirudin Market Value Growth Rate Analysis by Type: 2024 VS 2031

1.2.2 Natural Hirudin

1.2.3 Recombinant Hirudin

1.3 Hirudin by Application

1.3.1 Global Hirudin Market Value Growth Rate Analysis by Application: 2024 VS 2031

1.3.2 Thrombosis Disease

1.3.3 Tumor Disease

1.3.4 Others

1.4 Global Market Growth Prospects

1.4.1 Global Hirudin Production Value Estimates and Forecasts (2020-2031)

1.4.2 Global Hirudin Production Capacity Estimates and Forecasts (2020-2031)

1.4.3 Global Hirudin Production Estimates and Forecasts (2020-2031)

1.4.4 Global Hirudin Market Average Price Estimates and Forecasts (2020-2031)

1.5 Assumptions and Limitations

2 Market Competition by Manufacturers

2.1 Global Hirudin Production Market Share by Manufacturers (2020-2025)

2.2 Global Hirudin Production Value Market Share by Manufacturers (2020-2025)

2.3 Global Key Players of Hirudin, Industry Ranking, 2023 VS 2024

2.4 Global Hirudin Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.5 Global Hirudin Average Price by Manufacturers (2020-2025)

2.6 Global Key Manufacturers of Hirudin, Manufacturing Base Distribution and Headquarters

2.7 Global Key Manufacturers of Hirudin, Product Offered and Application

2.8 Global Key Manufacturers of Hirudin, Date of Enter into This Industry

2.9 Hirudin Market Competitive Situation and Trends

2.9.1 Hirudin Market Concentration Rate

2.9.2 Global 5 and 10 Largest Hirudin Players Market Share by Revenue

2.10 Mergers & Acquisitions, Expansion

3 Hirudin Production by Region

3.1 Global Hirudin Production Value Estimates and Forecasts by Region: 2020 VS 2024 VS 2031

3.2 Global Hirudin Production Value by Region (2020-2031)

3.2.1 Global Hirudin Production Value by Region (2020-2025)

3.2.2 Global Forecasted Production Value of Hirudin by Region (2026-2031)

3.3 Global Hirudin Production Estimates and Forecasts by Region: 2020 VS 2024 VS 2031

3.4 Global Hirudin Production Volume by Region (2020-2031)

3.4.1 Global Hirudin Production by Region (2020-2025)

3.4.2 Global Forecasted Production of Hirudin by Region (2026-2031)

3.5 Global Hirudin Market Price Analysis by Region (2020-2025)

3.6 Global Hirudin Production and Value, Year-over-Year Growth

3.6.1 North America Hirudin Production Value Estimates and Forecasts (2020-2031)

3.6.2 Europe Hirudin Production Value Estimates and Forecasts (2020-2031)

3.6.3 China Hirudin Production Value Estimates and Forecasts (2020-2031)

3.6.4 Japan Hirudin Production Value Estimates and Forecasts (2020-2031)

4 Hirudin Consumption by Region

4.1 Global Hirudin Consumption Estimates and Forecasts by Region: 2020 VS 2024 VS 2031

4.2 Global Hirudin Consumption by Region (2020-2031)

4.2.1 Global Hirudin Consumption by Region (2020-2025)

4.2.2 Global Hirudin Forecasted Consumption by Region (2026-2031)

4.3 North America

4.3.1 North America Hirudin Consumption Growth Rate by Country: 2020 VS 2024 VS 2031

4.3.2 North America Hirudin Consumption by Country (2020-2031)

4.3.3 U.S.

4.3.4 Canada

4.4 Europe

4.4.1 Europe Hirudin Consumption Growth Rate by Country: 2020 VS 2024 VS 2031

4.4.2 Europe Hirudin Consumption by Country (2020-2031)

4.4.3 Germany

4.4.4 France

4.4.5 U.K.

4.4.6 Italy

4.4.7 Russia

4.5 Asia Pacific

4.5.1 Asia Pacific Hirudin Consumption Growth Rate by Region: 2020 VS 2024 VS 2031

4.5.2 Asia Pacific Hirudin Consumption by Region (2020-2031)

4.5.3 China

4.5.4 Japan

4.5.5 South Korea

4.5.6 China Taiwan

4.5.7 Southeast Asia

4.5.8 India

4.6 Latin America, Middle East & Africa

4.6.1 Latin America, Middle East & Africa Hirudin Consumption Growth Rate by Country: 2020 VS 2024 VS 2031

4.6.2 Latin America, Middle East & Africa Hirudin Consumption by Country (2020-2031)

4.6.3 Mexico

4.6.4 Brazil

4.6.5 Turkey

4.6.6 GCC Countries

5 Segment by Type

5.1 Global Hirudin Production by Type (2020-2031)

5.1.1 Global Hirudin Production by Type (2020-2025)

5.1.2 Global Hirudin Production by Type (2026-2031)

5.1.3 Global Hirudin Production Market Share by Type (2020-2031)

5.2 Global Hirudin Production Value by Type (2020-2031)

5.2.1 Global Hirudin Production Value by Type (2020-2025)

5.2.2 Global Hirudin Production Value by Type (2026-2031)

5.2.3 Global Hirudin Production Value Market Share by Type (2020-2031)

5.3 Global Hirudin Price by Type (2020-2031)

6 Segment by Application

6.1 Global Hirudin Production by Application (2020-2031)

6.1.1 Global Hirudin Production by Application (2020-2025)

6.1.2 Global Hirudin Production by Application (2026-2031)

6.1.3 Global Hirudin Production Market Share by Application (2020-2031)

6.2 Global Hirudin Production Value by Application (2020-2031)

6.2.1 Global Hirudin Production Value by Application (2020-2025)

6.2.2 Global Hirudin Production Value by Application (2026-2031)

6.2.3 Global Hirudin Production Value Market Share by Application (2020-2031)

6.3 Global Hirudin Price by Application (2020-2031)

7 Key Companies Profiled

7.1 Novartis

7.1.1 Novartis Hirudin Company Information

7.1.2 Novartis Hirudin Product Portfolio

7.1.3 Novartis Hirudin Production, Value, Price and Gross Margin (2020-2025)

7.1.4 Novartis Main Business and Markets Served

7.1.5 Novartis Recent Developments/Updates

7.2 Teva Pharmaceuticals

7.2.1 Teva Pharmaceuticals Hirudin Company Information

7.2.2 Teva Pharmaceuticals Hirudin Product Portfolio

7.2.3 Teva Pharmaceuticals Hirudin Production, Value, Price and Gross Margin (2020-2025)

7.2.4 Teva Pharmaceuticals Main Business and Markets Served

7.2.5 Teva Pharmaceuticals Recent Developments/Updates

7.3 Pfizer, Inc

7.3.1 Pfizer, Inc Hirudin Company Information

7.3.2 Pfizer, Inc Hirudin Product Portfolio

7.3.3 Pfizer, Inc Hirudin Production, Value, Price and Gross Margin (2020-2025)

7.3.4 Pfizer, Inc Main Business and Markets Served

7.3.5 Pfizer, Inc Recent Developments/Updates

7.4 Pentapharm

7.4.1 Pentapharm Hirudin Company Information

7.4.2 Pentapharm Hirudin Product Portfolio

7.4.3 Pentapharm Hirudin Production, Value, Price and Gross Margin (2020-2025)

7.4.4 Pentapharm Main Business and Markets Served

7.4.5 Pentapharm Recent Developments/Updates

7.5 DUOPUTAI

7.5.1 DUOPUTAI Hirudin Company Information

7.5.2 DUOPUTAI Hirudin Product Portfolio

7.5.3 DUOPUTAI Hirudin Production, Value, Price and Gross Margin (2020-2025)

7.5.4 DUOPUTAI Main Business and Markets Served

7.5.5 DUOPUTAI Recent Developments/Updates

7.6 Abbott

7.6.1 Abbott Hirudin Company Information

7.6.2 Abbott Hirudin Product Portfolio

7.6.3 Abbott Hirudin Production, Value, Price and Gross Margin (2020-2025)

7.6.4 Abbott Main Business and Markets Served

7.6.5 Abbott Recent Developments/Updates

7.7 Keyken

7.7.1 Keyken Hirudin Company Information

7.7.2 Keyken Hirudin Product Portfolio

7.7.3 Keyken Hirudin Production, Value, Price and Gross Margin (2020-2025)

7.7.4 Keyken Main Business and Markets Served

7.7.5 Keyken Recent Developments/Updates

7.8 Minapharm

7.8.1 Minapharm Hirudin Company Information

7.8.2 Minapharm Hirudin Product Portfolio

7.8.3 Minapharm Hirudin Production, Value, Price and Gross Margin (2020-2025)

7.8.4 Minapharm Main Business and Markets Served

7.8.5 Minapharm Recent Developments/Updates

7.9 Salubris Bio

7.9.1 Salubris Bio Hirudin Company Information

7.9.2 Salubris Bio Hirudin Product Portfolio

7.9.3 Salubris Bio Hirudin Production, Value, Price and Gross Margin (2020-2025)

7.9.4 Salubris Bio Main Business and Markets Served

7.9.5 Salubris Bio Recent Developments/Updates

7.10 Hoechst AG

7.10.1 Hoechst AG Hirudin Company Information

7.10.2 Hoechst AG Hirudin Product Portfolio

7.10.3 Hoechst AG Hirudin Production, Value, Price and Gross Margin (2020-2025)

7.10.4 Hoechst AG Main Business and Markets Served

7.10.5 Hoechst AG Recent Developments/Updates

7.11 Ciba-Geigy

7.11.1 Ciba-Geigy Hirudin Company Information

7.11.2 Ciba-Geigy Hirudin Product Portfolio

7.11.3 Ciba-Geigy Hirudin Production, Value, Price and Gross Margin (2020-2025)

7.11.4 Ciba-Geigy Main Business and Markets Served

7.11.5 Ciba-Geigy Recent Developments/Updates

7.12 Boehringer Ingelheim

7.12.1 Boehringer Ingelheim Hirudin Company Information

7.12.2 Boehringer Ingelheim Hirudin Product Portfolio

7.12.3 Boehringer Ingelheim Hirudin Production, Value, Price and Gross Margin (2020-2025)

7.12.4 Boehringer Ingelheim Main Business and Markets Served

7.12.5 Boehringer Ingelheim Recent Developments/Updates

7.13 Sanofi

7.13.1 Sanofi Hirudin Company Information

7.13.2 Sanofi Hirudin Product Portfolio

7.13.3 Sanofi Hirudin Production, Value, Price and Gross Margin (2020-2025)

7.13.4 Sanofi Main Business and Markets Served

7.13.5 Sanofi Recent Developments/Updates

7.14 Xellia Pharmaceuticals

7.14.1 Xellia Pharmaceuticals Hirudin Company Information

7.14.2 Xellia Pharmaceuticals Hirudin Product Portfolio

7.14.3 Xellia Pharmaceuticals Hirudin Production, Value, Price and Gross Margin (2020-2025)

7.14.4 Xellia Pharmaceuticals Main Business and Markets Served

7.14.5 Xellia Pharmaceuticals Recent Developments/Updates

7.15 Haplogen Pharmaceuticals

7.15.1 Haplogen Pharmaceuticals Hirudin Company Information

7.15.2 Haplogen Pharmaceuticals Hirudin Product Portfolio

7.15.3 Haplogen Pharmaceuticals Hirudin Production, Value, Price and Gross Margin (2020-2025)

7.15.4 Haplogen Pharmaceuticals Main Business and Markets Served

7.15.5 Haplogen Pharmaceuticals Recent Developments/Updates

7.16 Shenzhen Kangtai Biological

7.16.1 Shenzhen Kangtai Biological Hirudin Company Information

7.16.2 Shenzhen Kangtai Biological Hirudin Product Portfolio

7.16.3 Shenzhen Kangtai Biological Hirudin Production, Value, Price and Gross Margin (2020-2025)

7.16.4 Shenzhen Kangtai Biological Main Business and Markets Served

7.16.5 Shenzhen Kangtai Biological Recent Developments/Updates

7.17 Dong-A ST

7.17.1 Dong-A ST Hirudin Company Information

7.17.2 Dong-A ST Hirudin Product Portfolio

7.17.3 Dong-A ST Hirudin Production, Value, Price and Gross Margin (2020-2025)

7.17.4 Dong-A ST Main Business and Markets Served

7.17.5 Dong-A ST Recent Developments/Updates

8 Industry Chain and Sales Channels Analysis

8.1 Hirudin Industry Chain Analysis

8.2 Hirudin Raw Material Supply Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.3 Hirudin Production Mode & Process Analysis

8.4 Hirudin Sales and Marketing

8.4.1 Hirudin Sales Channels

8.4.2 Hirudin Distributors

8.5 Hirudin Customer Analysis

9 Hirudin Market Dynamics

9.1 Hirudin Industry Trends

9.2 Hirudin Market Drivers

9.3 Hirudin Market Challenges

9.4 Hirudin Market Restraints

10 Research Findings and Conclusion

11 Methodology and Data Source

11.1 Methodology/Research Approach

11.1.1 Research Programs/Design

11.1.2 Market Size Estimation

11.1.3 Market Breakdown and Data Triangulation

11.2 Data Source

11.2.1 Secondary Sources

11.2.2 Primary Sources

11.3 Author List

11.4 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. Global Hirudin Market Value by Type, (US$ Million) & (2024 VS 2031)

Table 2. Global Hirudin Market Value by Application, (US$ Million) & (2024 VS 2031)

Table 3. Global Hirudin Production Capacity (Tons) by Manufacturers in 2024

Table 4. Global Hirudin Production by Manufacturers (2020-2025) & (Tons)

Table 5. Global Hirudin Production Market Share by Manufacturers (2020-2025)

Table 6. Global Hirudin Production Value by Manufacturers (2020-2025) & (US$ Million)

Table 7. Global Hirudin Production Value Share by Manufacturers (2020-2025)

Table 8. Global Key Players of Hirudin, Industry Ranking, 2023 VS 2024

Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Production Value in Hirudin as of 2024)

Table 10. Global Market Hirudin Average Price by Manufacturers (US$/kg) & (2020-2025)

Table 11. Global Key Manufacturers of Hirudin, Manufacturing Base Distribution and Headquarters

Table 12. Global Key Manufacturers of Hirudin, Product Offered and Application

Table 13. Global Key Manufacturers of Hirudin, Date of Enter into This Industry

Table 14. Global Hirudin Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 15. Mergers & Acquisitions, Expansion Plans

Table 16. Global Hirudin Production Value by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 17. Global Hirudin Production Value (US$ Million) by Region (2020-2025)

Table 18. Global Hirudin Production Value Market Share by Region (2020-2025)

Table 19. Global Hirudin Production Value (US$ Million) Forecast by Region (2026-2031)

Table 20. Global Hirudin Production Value Market Share Forecast by Region (2026-2031)

Table 21. Global Hirudin Production Comparison by Region: 2020 VS 2024 VS 2031 (Tons)

Table 22. Global Hirudin Production (Tons) by Region (2020-2025)

Table 23. Global Hirudin Production Market Share by Region (2020-2025)

Table 24. Global Hirudin Production (Tons) Forecast by Region (2026-2031)

Table 25. Global Hirudin Production Market Share Forecast by Region (2026-2031)

Table 26. Global Hirudin Market Average Price (US$/kg) by Region (2020-2025)

Table 27. Global Hirudin Market Average Price (US$/kg) by Region (2026-2031)

Table 28. Global Hirudin Consumption Growth Rate by Region: 2020 VS 2024 VS 2031 (Tons)

Table 29. Global Hirudin Consumption by Region (2020-2025) & (Tons)

Table 30. Global Hirudin Consumption Market Share by Region (2020-2025)

Table 31. Global Hirudin Forecasted Consumption by Region (2026-2031) & (Tons)

Table 32. Global Hirudin Forecasted Consumption Market Share by Region (2026-2031)

Table 33. North America Hirudin Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 (Tons)

Table 34. North America Hirudin Consumption by Country (2020-2025) & (Tons)

Table 35. North America Hirudin Consumption by Country (2026-2031) & (Tons)

Table 36. Europe Hirudin Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 (Tons)

Table 37. Europe Hirudin Consumption by Country (2020-2025) & (Tons)

Table 38. Europe Hirudin Consumption by Country (2026-2031) & (Tons)

Table 39. Asia Pacific Hirudin Consumption Growth Rate by Region: 2020 VS 2024 VS 2031 (Tons)

Table 40. Asia Pacific Hirudin Consumption by Region (2020-2025) & (Tons)

Table 41. Asia Pacific Hirudin Consumption by Region (2026-2031) & (Tons)

Table 42. Latin America, Middle East & Africa Hirudin Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 (Tons)

Table 43. Latin America, Middle East & Africa Hirudin Consumption by Country (2020-2025) & (Tons)

Table 44. Latin America, Middle East & Africa Hirudin Consumption by Country (2026-2031) & (Tons)

Table 45. Global Hirudin Production (Tons) by Type (2020-2025)

Table 46. Global Hirudin Production (Tons) by Type (2026-2031)

Table 47. Global Hirudin Production Market Share by Type (2020-2025)

Table 48. Global Hirudin Production Market Share by Type (2026-2031)

Table 49. Global Hirudin Production Value (US$ Million) by Type (2020-2025)

Table 50. Global Hirudin Production Value (US$ Million) by Type (2026-2031)

Table 51. Global Hirudin Production Value Market Share by Type (2020-2025)

Table 52. Global Hirudin Production Value Market Share by Type (2026-2031)

Table 53. Global Hirudin Price (US$/kg) by Type (2020-2025)

Table 54. Global Hirudin Price (US$/kg) by Type (2026-2031)

Table 55. Global Hirudin Production (Tons) by Application (2020-2025)

Table 56. Global Hirudin Production (Tons) by Application (2026-2031)

Table 57. Global Hirudin Production Market Share by Application (2020-2025)

Table 58. Global Hirudin Production Market Share by Application (2026-2031)

Table 59. Global Hirudin Production Value (US$ Million) by Application (2020-2025)

Table 60. Global Hirudin Production Value (US$ Million) by Application (2026-2031)

Table 61. Global Hirudin Production Value Market Share by Application (2020-2025)

Table 62. Global Hirudin Production Value Market Share by Application (2026-2031)

Table 63. Global Hirudin Price (US$/kg) by Application (2020-2025)

Table 64. Global Hirudin Price (US$/kg) by Application (2026-2031)

Table 65. Novartis Hirudin Company Information

Table 66. Novartis Hirudin Specification and Application

Table 67. Novartis Hirudin Production (Tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)

Table 68. Novartis Main Business and Markets Served

Table 69. Novartis Recent Developments/Updates

Table 70. Teva Pharmaceuticals Hirudin Company Information

Table 71. Teva Pharmaceuticals Hirudin Specification and Application

Table 72. Teva Pharmaceuticals Hirudin Production (Tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)

Table 73. Teva Pharmaceuticals Main Business and Markets Served

Table 74. Teva Pharmaceuticals Recent Developments/Updates

Table 75. Pfizer, Inc Hirudin Company Information

Table 76. Pfizer, Inc Hirudin Specification and Application

Table 77. Pfizer, Inc Hirudin Production (Tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)

Table 78. Pfizer, Inc Main Business and Markets Served

Table 79. Pfizer, Inc Recent Developments/Updates

Table 80. Pentapharm Hirudin Company Information

Table 81. Pentapharm Hirudin Specification and Application

Table 82. Pentapharm Hirudin Production (Tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)

Table 83. Pentapharm Main Business and Markets Served

Table 84. Pentapharm Recent Developments/Updates

Table 85. DUOPUTAI Hirudin Company Information

Table 86. DUOPUTAI Hirudin Specification and Application

Table 87. DUOPUTAI Hirudin Production (Tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)

Table 88. DUOPUTAI Main Business and Markets Served

Table 89. DUOPUTAI Recent Developments/Updates

Table 90. Abbott Hirudin Company Information

Table 91. Abbott Hirudin Specification and Application

Table 92. Abbott Hirudin Production (Tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)

Table 93. Abbott Main Business and Markets Served

Table 94. Abbott Recent Developments/Updates

Table 95. Keyken Hirudin Company Information

Table 96. Keyken Hirudin Specification and Application

Table 97. Keyken Hirudin Production (Tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)

Table 98. Keyken Main Business and Markets Served

Table 99. Keyken Recent Developments/Updates

Table 100. Minapharm Hirudin Company Information

Table 101. Minapharm Hirudin Specification and Application

Table 102. Minapharm Hirudin Production (Tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)

Table 103. Minapharm Main Business and Markets Served

Table 104. Minapharm Recent Developments/Updates

Table 105. Salubris Bio Hirudin Company Information

Table 106. Salubris Bio Hirudin Specification and Application

Table 107. Salubris Bio Hirudin Production (Tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)

Table 108. Salubris Bio Main Business and Markets Served

Table 109. Salubris Bio Recent Developments/Updates

Table 110. Hoechst AG Hirudin Company Information

Table 111. Hoechst AG Hirudin Specification and Application

Table 112. Hoechst AG Hirudin Production (Tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)

Table 113. Hoechst AG Main Business and Markets Served

Table 114. Hoechst AG Recent Developments/Updates

Table 115. Ciba-Geigy Hirudin Company Information

Table 116. Ciba-Geigy Hirudin Specification and Application

Table 117. Ciba-Geigy Hirudin Production (Tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)

Table 118. Ciba-Geigy Main Business and Markets Served

Table 119. Ciba-Geigy Recent Developments/Updates

Table 120. Boehringer Ingelheim Hirudin Company Information

Table 121. Boehringer Ingelheim Hirudin Specification and Application

Table 122. Boehringer Ingelheim Hirudin Production (Tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)

Table 123. Boehringer Ingelheim Main Business and Markets Served

Table 124. Boehringer Ingelheim Recent Developments/Updates

Table 125. Sanofi Hirudin Company Information

Table 126. Sanofi Hirudin Specification and Application

Table 127. Sanofi Hirudin Production (Tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)

Table 128. Sanofi Main Business and Markets Served

Table 129. Sanofi Recent Developments/Updates

Table 130. Xellia Pharmaceuticals Hirudin Company Information

Table 131. Xellia Pharmaceuticals Hirudin Specification and Application

Table 132. Xellia Pharmaceuticals Hirudin Production (Tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)

Table 133. Xellia Pharmaceuticals Main Business and Markets Served

Table 134. Xellia Pharmaceuticals Recent Developments/Updates

Table 135. Haplogen Pharmaceuticals Hirudin Company Information

Table 136. Haplogen Pharmaceuticals Hirudin Specification and Application

Table 137. Haplogen Pharmaceuticals Hirudin Production (Tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)

Table 138. Haplogen Pharmaceuticals Main Business and Markets Served

Table 139. Haplogen Pharmaceuticals Recent Developments/Updates

Table 140. Shenzhen Kangtai Biological Hirudin Company Information

Table 141. Shenzhen Kangtai Biological Hirudin Specification and Application

Table 142. Shenzhen Kangtai Biological Hirudin Production (Tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)

Table 143. Shenzhen Kangtai Biological Main Business and Markets Served

Table 144. Shenzhen Kangtai Biological Recent Developments/Updates

Table 145. Dong-A ST Hirudin Company Information

Table 146. Dong-A ST Hirudin Specification and Application

Table 147. Dong-A ST Hirudin Production (Tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)

Table 148. Dong-A ST Main Business and Markets Served

Table 149. Dong-A ST Recent Developments/Updates

Table 150. Key Raw Materials Lists

Table 151. Raw Materials Key Suppliers Lists

Table 152. Hirudin Distributors List

Table 153. Hirudin Customers List

Table 154. Hirudin Market Trends

Table 155. Hirudin Market Drivers

Table 156. Hirudin Market Challenges

Table 157. Hirudin Market Restraints

Table 158. Research Programs/Design for This Report

Table 159. Key Data Information from Secondary Sources

Table 160. Key Data Information from Primary Sources

Table 161. Authors List of This Report

List of Figures

Figure 1. Product Picture of Hirudin

Figure 2. Global Hirudin Market Value by Type, (US$ Million) & (2020-2031)

Figure 3. Global Hirudin Market Share by Type: 2024 VS 2031

Figure 4. Natural Hirudin Product Picture

Figure 5. Recombinant Hirudin Product Picture

Figure 6. Global Hirudin Market Value by Application, (US$ Million) & (2020-2031)

Figure 7. Global Hirudin Market Share by Application: 2024 VS 2031

Figure 8. Thrombosis Disease

Figure 9. Tumor Disease

Figure 10. Others

Figure 11. Global Hirudin Production Value (US$ Million), 2020 VS 2024 VS 2031

Figure 12. Global Hirudin Production Value (US$ Million) & (2020-2031)

Figure 13. Global Hirudin Production Capacity (Tons) & (2020-2031)

Figure 14. Global Hirudin Production (Tons) & (2020-2031)

Figure 15. Global Hirudin Average Price (US$/kg) & (2020-2031)

Figure 16. Hirudin Report Years Considered

Figure 17. Hirudin Production Share by Manufacturers in 2024

Figure 18. Global Hirudin Production Value Share by Manufacturers (2024)

Figure 19. Hirudin Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 20. The Global 5 and 10 Largest Players: Market Share by Hirudin Revenue in 2024

Figure 21. Global Hirudin Production Value by Region: 2020 VS 2024 VS 2031 (US$ Million)

Figure 22. Global Hirudin Production Value Market Share by Region: 2020 VS 2024 VS 2031

Figure 23. Global Hirudin Production Comparison by Region: 2020 VS 2024 VS 2031 (Tons)

Figure 24. Global Hirudin Production Market Share by Region: 2020 VS 2024 VS 2031

Figure 25. North America Hirudin Production Value (US$ Million) Growth Rate (2020-2031)

Figure 26. Europe Hirudin Production Value (US$ Million) Growth Rate (2020-2031)

Figure 27. China Hirudin Production Value (US$ Million) Growth Rate (2020-2031)

Figure 28. Japan Hirudin Production Value (US$ Million) Growth Rate (2020-2031)

Figure 29. Global Hirudin Consumption by Region: 2020 VS 2024 VS 2031 (Tons)

Figure 30. Global Hirudin Consumption Market Share by Region: 2020 VS 2024 VS 2031

Figure 31. North America Hirudin Consumption and Growth Rate (2020-2031) & (Tons)

Figure 32. North America Hirudin Consumption Market Share by Country (2020-2031)

Figure 33. U.S. Hirudin Consumption and Growth Rate (2020-2031) & (Tons)

Figure 34. Canada Hirudin Consumption and Growth Rate (2020-2031) & (Tons)

Figure 35. Europe Hirudin Consumption and Growth Rate (2020-2031) & (Tons)

Figure 36. Europe Hirudin Consumption Market Share by Country (2020-2031)

Figure 37. Germany Hirudin Consumption and Growth Rate (2020-2031) & (Tons)

Figure 38. France Hirudin Consumption and Growth Rate (2020-2031) & (Tons)

Figure 39. U.K. Hirudin Consumption and Growth Rate (2020-2031) & (Tons)

Figure 40. Italy Hirudin Consumption and Growth Rate (2020-2031) & (Tons)

Figure 41. Russia Hirudin Consumption and Growth Rate (2020-2031) & (Tons)

Figure 42. Asia Pacific Hirudin Consumption and Growth Rate (2020-2031) & (Tons)

Figure 43. Asia Pacific Hirudin Consumption Market Share by Region (2020-2031)

Figure 44. China Hirudin Consumption and Growth Rate (2020-2031) & (Tons)

Figure 45. Japan Hirudin Consumption and Growth Rate (2020-2031) & (Tons)

Figure 46. South Korea Hirudin Consumption and Growth Rate (2020-2031) & (Tons)

Figure 47. China Taiwan Hirudin Consumption and Growth Rate (2020-2031) & (Tons)

Figure 48. Southeast Asia Hirudin Consumption and Growth Rate (2020-2031) & (Tons)

Figure 49. India Hirudin Consumption and Growth Rate (2020-2031) & (Tons)

Figure 50. Latin America, Middle East & Africa Hirudin Consumption and Growth Rate (2020-2031) & (Tons)

Figure 51. Latin America, Middle East & Africa Hirudin Consumption Market Share by Country (2020-2031)

Figure 52. Mexico Hirudin Consumption and Growth Rate (2020-2031) & (Tons)

Figure 53. Brazil Hirudin Consumption and Growth Rate (2020-2031) & (Tons)

Figure 54. Turkey Hirudin Consumption and Growth Rate (2020-2031) & (Tons)

Figure 55. GCC Countries Hirudin Consumption and Growth Rate (2020-2031) & (Tons)

Figure 56. Global Production Market Share of Hirudin by Type (2020-2031)

Figure 57. Global Production Value Market Share of Hirudin by Type (2020-2031)

Figure 58. Global Hirudin Price (US$/kg) by Type (2020-2031)

Figure 59. Global Production Market Share of Hirudin by Application (2020-2031)

Figure 60. Global Production Value Market Share of Hirudin by Application (2020-2031)

Figure 61. Global Hirudin Price (US$/kg) by Application (2020-2031)

Figure 62. Hirudin Value Chain

Figure 63. Channels of Distribution (Direct Vs Distribution)

Figure 64. Bottom-up and Top-down Approaches for This Report

Figure 65. Data Triangulation

KEY QUESTIONS ADDRESSED BY THE REPORT

Which companies rank high in the global Hirudin market? zhanKai

The top companies in the global Hirudin market are Novartis、Teva Pharmaceuticals、Pfizer, Inc.

What was the global market size of Hirudin in 2025? shouQi

Which region is expected to have the highest market share? shouQi

What is the annual compound growth rate of the global Hirudin market size from 2025 to 2031? shouQi

What was the global market size of Hirudin in 2031? shouQi

Related Reports

Global Hirudin Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Hirudin market size was US$ 4341 million in 2025 and is forecast to reach a readjusted size of US$ 5359 million by 2032 with a CAGR of 3.1% during the forecast period 2026-2032.
Published Date: 2026-01-04
Pages: 107
USD 4250.00
(Single User License)
Global Hirudin Market Research Report 2026
The global Hirudin market was valued at US$ 4341 million in 2025 and is anticipated to reach US$ 5359 million by 2032, at a CAGR of 3.1% from 2026 to 2032.
Published Date: 2026-01-04
Pages: 150
USD 2900.00
(Single User License)
Hirudin- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Hirudin was estimated to be worth US$ 4341 million in 2025 and is projected to reach US$ 5359 million, growing at a CAGR of 3.1% from 2026 to 2032.
Published Date: 2026-01-04
Pages: 138
USD 3950.00
(Single User License)
Global Hirudin Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Hirudin market is projected to grow from US$ 4223 million in 2024 to US$ 5214 million by 2031, at a CAGR of 3.1% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-09-11
Pages: 180
USD 4900.00
(Single User License)
Hirudin - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Hirudin was estimated to be worth US$ 4223 million in 2024 and is forecast to a readjusted size of US$ 5214 million by 2031 with a CAGR of 3.1% during the forecast period 2025-2031.
Published Date: 2025-06-11
Pages: 142
USD 3950.00
(Single User License)
Global Hirudin Market Insights, Forecast to 2031
The global Hirudin market is projected to grow from US$ 4341 million in 2025 to US$ 5214 million by 2031, at a Compound Annual Growth Rate (CAGR) of 3.1% during the forecast period.
Published Date: 2025-06-11
Pages: 180
USD 4900.00
(Single User License)
Global Hirudin Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Hirudin market size was US$ 4223 million in 2024 and is forecast to a readjusted size of US$ 5214 million by 2031 with a CAGR of 3.1% during the forecast period 2025-2031.
Published Date: 2025-06-11
Pages: 106
USD 4250.00
(Single User License)
Global Hirudin Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
In 2024, the global market size of Hirudin was estimated to be worth US$ 4223 million and is forecast to reach approximately US$ 5214 million by 2031 with a CAGR of 3.1% during the forecast period 2025-2031.
Published Date: 2025-03-28
Pages: 139
USD 5900.00
(Single User License)
Hirudin- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Hirudin was estimated to be worth US$ 4223 million in 2024 and is forecast to a readjusted size of US$ 5214 million by 2031 with a CAGR of 3.1% during the forecast period 2025-2031.
Published Date: 2025-01-16
Pages: 97
USD 3950.00
(Single User License)
Global Hirudin Industry Research Report, Growth Trends and Competitive Analysis 2024-2030
This report studies the Hirudin market. Hirudin is a naturally occurring peptide in the salivary glands of medicinal leeches (such as Hirudo medicinalis) that has a blood anticoagulant property. Hirudin is the most potent natural inhibitor of thrombin. Hirudin (hirudin) is a Leech (Leech) and salivary glands have been extracted from a variety of active ingredients in the activity of the most significant and most studied ingredients, which is 65-66 amino acids from the small molecules of protein (peptide) . Hirudin have strong inhibitory effect on thrombin is the strongest so far found in the natural specific inhibitor of thrombin. Animal experiments and clinical studies have shown that hirudin can be effective anticoagulant, antithrombotic, and prevent thrombin-catalyzed activation of coagulation factors and platelet reactions and blood stasis phenomenon further. In addition, it also inhibited thrombin-induced fibroblast proliferation, and thrombin stimulation of endothelial cells. Compared with heparin, which not only use less, do not cause bleeding, is not dependent on endogenous cofactor; and heparin have caused the risk of bleeding, disseminated intravascular coagulation in the pathogenesis of antithrombin III are reduced This will limit the efficacy of heparin, using leeches will have good results.
Published Date: 2024-04-17
Pages: 154
USD 5600.00
(Single User License)

Global Hirudin Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Hirudin market size was US$ 4341 million in 2025 and is forecast to reach a readjusted size of US$ 5359 million by 2032 with a CAGR of 3.1% during the forecast period 2026-2032.
Published: 2026-01-04
Pages: 107
USD 4250.00 (Single User License)
Global Hirudin Market Research Report 2026
The global Hirudin market was valued at US$ 4341 million in 2025 and is anticipated to reach US$ 5359 million by 2032, at a CAGR of 3.1% from 2026 to 2032.
Published: 2026-01-04
Pages: 150
USD 2900.00 (Single User License)
Hirudin- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Hirudin was estimated to be worth US$ 4341 million in 2025 and is projected to reach US$ 5359 million, growing at a CAGR of 3.1% from 2026 to 2032.
Published: 2026-01-04
Pages: 138
USD 3950.00 (Single User License)
Global Hirudin Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Hirudin market is projected to grow from US$ 4223 million in 2024 to US$ 5214 million by 2031, at a CAGR of 3.1% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-09-11
Pages: 180
USD 4900.00 (Single User License)
Hirudin - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Hirudin was estimated to be worth US$ 4223 million in 2024 and is forecast to a readjusted size of US$ 5214 million by 2031 with a CAGR of 3.1% during the forecast period 2025-2031.
Published: 2025-06-11
Pages: 142
USD 3950.00 (Single User License)
Global Hirudin Market Insights, Forecast to 2031
The global Hirudin market is projected to grow from US$ 4341 million in 2025 to US$ 5214 million by 2031, at a Compound Annual Growth Rate (CAGR) of 3.1% during the forecast period.
Published: 2025-06-11
Pages: 180
USD 4900.00 (Single User License)
Global Hirudin Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Hirudin market size was US$ 4223 million in 2024 and is forecast to a readjusted size of US$ 5214 million by 2031 with a CAGR of 3.1% during the forecast period 2025-2031.
Published: 2025-06-11
Pages: 106
USD 4250.00 (Single User License)
Global Hirudin Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
In 2024, the global market size of Hirudin was estimated to be worth US$ 4223 million and is forecast to reach approximately US$ 5214 million by 2031 with a CAGR of 3.1% during the forecast period 2025-2031.
Published: 2025-03-28
Pages: 139
USD 5900.00 (Single User License)
Hirudin- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Hirudin was estimated to be worth US$ 4223 million in 2024 and is forecast to a readjusted size of US$ 5214 million by 2031 with a CAGR of 3.1% during the forecast period 2025-2031.
Published: 2025-01-16
Pages: 97
USD 3950.00 (Single User License)
Global Hirudin Industry Research Report, Growth Trends and Competitive Analysis 2024-2030
This report studies the Hirudin market. Hirudin is a naturally occurring peptide in the salivary glands of medicinal leeches (such as Hirudo medicinalis) that has a blood anticoagulant property. Hirudin is the most potent natural inhibitor of thrombin. Hirudin (hirudin) is a Leech (Leech) and salivary glands have been extracted from a variety of active ingredients in the activity of the most significant and most studied ingredients, which is 65-66 amino acids from the small molecules of protein (peptide) . Hirudin have strong inhibitory effect on thrombin is the strongest so far found in the natural specific inhibitor of thrombin. Animal experiments and clinical studies have shown that hirudin can be effective anticoagulant, antithrombotic, and prevent thrombin-catalyzed activation of coagulation factors and platelet reactions and blood stasis phenomenon further. In addition, it also inhibited thrombin-induced fibroblast proliferation, and thrombin stimulation of endothelial cells. Compared with heparin, which not only use less, do not cause bleeding, is not dependent on endogenous cofactor; and heparin have caused the risk of bleeding, disseminated intravascular coagulation in the pathogenesis of antithrombin III are reduced This will limit the efficacy of heparin, using leeches will have good results.
Published: 2024-04-17
Pages: 154
USD 5600.00 (Single User License)